Literature DB >> 10096719

The nature and extent of drug-related hospitalisations in Australia.

E E Roughead1.   

Abstract

In order to determine the nature and extent of drug-related hospitalisation in Australia, the Australian National Hospital Morbidity Collection, the Quality in Australian Health Care Study and Australian studies assessing drug-related hospital admissions were reviewed. The incidence figures, drugs and conditions most commonly implicated, and estimates of avoidability of medication-related problems were compared. The three data sources were found to provide consistent results, with all sources implicating cytotoxics, antirheumatics, anticoagulants, corticosteroids, antihypertensives and cardiovascular agents in medication-related hospitalisations. Estimates of the extent of the problem were also consistent, suggesting that at least 80 000 medication-related hospitalisations occur in Australia each year; between 32% and 69% of these hospitalisations were considered avoidable. It was concluded that medication-related hospitalisations are a major public health problem in Australia. The avoidability estimates suggest that much can and should be done to reduce this problem.

Entities:  

Mesh:

Year:  1999        PMID: 10096719     DOI: 10.1046/j.1440-1762.1999.00288.x

Source DB:  PubMed          Journal:  J Qual Clin Pract        ISSN: 1320-5455


  15 in total

1.  Pharmacists' interventions in prescribing errors at hospital discharge: an observational study in the context of an electronic prescribing system in a UK teaching hospital.

Authors:  Derar H Abdel-Qader; Lindsay Harper; Judith A Cantrill; Mary P Tully
Journal:  Drug Saf       Date:  2010-11-01       Impact factor: 5.606

2.  Some unintended consequences of information technology in health care: the nature of patient care information system-related errors.

Authors:  Joan S Ash; Marc Berg; Enrico Coiera
Journal:  J Am Med Inform Assoc       Date:  2003-11-21       Impact factor: 4.497

3.  Drug-related problems identified in medication reviews by Australian pharmacists.

Authors:  Andrew C Stafford; Peter C Tenni; Gregory M Peterson; Shane L Jackson; Anne Hejlesen; Christine Villesen; Mette Rasmussen
Journal:  Pharm World Sci       Date:  2009-02-26

4.  Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003.

Authors:  Min Zhang; C D'Arcy J Holman; David B Preen; Kate Brameld
Journal:  Br J Clin Pharmacol       Date:  2007-02       Impact factor: 4.335

5.  Pharmacist-Led Home Medicines Review and Residential Medication Management Review: The Australian Model.

Authors:  Timothy F Chen
Journal:  Drugs Aging       Date:  2016-03       Impact factor: 3.923

6.  Drug-related problems identified in post-discharge medication reviews for patients taking warfarin.

Authors:  Leanne Stafford; Andrew Stafford; Josephine Hughes; Manya Angley; Luke Bereznicki; Gregory Peterson
Journal:  Int J Clin Pharm       Date:  2011-05-19

7.  The effect of pharmacotherapeutic counseling on readmissions and emergency department visits.

Authors:  Srecko Marusic; Nives Gojo-Tomic; Viktorija Erdeljic; Vesna Bacic-Vrca; Miljenko Franic; Marijan Kirin; Velimir Bozikov
Journal:  Int J Clin Pharm       Date:  2012-09-25

8.  Study on drug related hospital admissions in a tertiary care hospital in South India.

Authors:  M Sonal Sekhar; C Adheena Mary; P G Anju; Nishana Ameer Hamsa
Journal:  Saudi Pharm J       Date:  2011-05-04       Impact factor: 4.330

9.  A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.

Authors:  Michael J Dooley; Karen M Allen; Christopher J Doecke; Kirsten J Galbraith; George R Taylor; Jennifer Bright; Dianne L Carey
Journal:  Br J Clin Pharmacol       Date:  2004-04       Impact factor: 4.335

10.  A role for pharmacists in community-based post-discharge warfarin management: protocol for the 'the role of community pharmacy in post hospital management of patients initiated on warfarin' study.

Authors:  Leanne Stafford; Gregory M Peterson; Luke R E Bereznicki; Shane L Jackson
Journal:  BMC Health Serv Res       Date:  2011-01-25       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.